Studies have suggested that that the concentrations of Lp-PLA2 and sPLA2 are high in patients with metabolic diseases accompanied by IR, such as obesity [26, 27] and polycystic ovary syndrome [28]. Here, PLA2G7 is linked to obesity due to melanocortin 4 receptor deficiency.